Hybrid Telerehabilitation for Anterior Knee Pain in Routine Physiotherapy Practice
ConditionAnterior Knee Pain
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFarraj Miguel
About this trial
This study will examine how hybrid telerehabilitation is used in routine physiotherapy care for adults with anterior knee pain. Approximately 30 participants will be followed for 72 weeks while receiving individualized treatment from their physiotherapist, supported by the moveUP mobile application. The application provides prescribed exercises, educational information, communication with the physiotherapist, and progress monitoring.
The study will assess adherence to rehabilitation, pain, knee function, quality of life, psychological factors, and physical activity. It will also explore whether patient adherence and physiotherapist engagement are associated with clinical outcomes. Interviews with patients and healthcare professionals will examine barriers and facilitators to using the platform in routine care.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18 years or older.
Clinical diagnosis of anterior knee pain, including patellofemoral pain, patellar tendinopathy, Hoffa's fat pad syndrome, chondromalacia, or femoropatellar, tibiopatellar, or tibiofemoral osteoarthritis not requiring surgery.
Access to a smartphone compatible with the moveUP application.
Disqualifiers
Currently awaiting spine or lower-limb surgery.
Lower-limb surgery or other invasive intervention within the previous two years.
Joint prosthesis.
Acute trauma to the trunk or lower limbs, or fracture, dislocation, or other musculoskeletal pathology of the affected lower limb within the previous six months.
Trial design
Design model
Single group
Treatments tested in this trial
Hybrid Telerehabilitation
BehavioralHybrid telerehabilitation combining routine physiotherapy with the moveUP mobile application for adults with anterior knee pain. The platform supports individualized exercise prescription, educational modules, patient-physiotherapist communication, and progress monitoring. Exercise selection, frequency, and progression are determined by the treating physiotherapist according to patient needs. Participants are followed for 72 weeks.
Treatment groups
30 Participants
are divided into 1 treatment groupGroup A: Hybrid TelerehabilitationExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Exercise Adherence (ATEMPT Score)
Exercise adherence will be assessed using the Adherence to Exercise for Musculoskeletal Pain Tool (ATEMPT). Total scores range from 6 to 30, with higher scores indicating greater adherence.
Time frame
Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 722
Pain Intensity (Visual Analog Scale)
Pain intensity will be measured using a 0-100 mm Visual Analog Scale (VAS), where 0 indicates no pain and 100 indicates the worst pain imaginable. Higher scores indicate greater pain intensity.
Time frame
Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72Secondary outcomes
1
Knee Function (Anterior Knee Pain Scale)
The Anterior Knee Pain Scale assesses symptoms and functional limitations associated with anterior knee pain. The total score ranges from 0 to 100, with higher scores indicating better function and fewer symptoms
Time frame
aseline and weeks 6, 12, 18, 24, 36, 48, 60, and 722
Health-Related Quality of Life (EQ-5D)
Health-related quality of life will be assessed using the EuroQol 5-Dimension 5-Level (EQ-5D-5L) questionnaire. Responses will be converted into a utility index using the Belgian value set. Scores range from -0.532 to 1, with higher scores indicating better health-related quality of life.
Time frame
Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 723
Fear of Movement (Tampa Scale for Kinesiophobia)
The 11-item Tampa Scale for Kinesiophobia assesses fear of movement or reinjury. The total score ranges from 11 to 44, with higher scores indicating greater kinesiophobia and therefore a worse outcome
Time frame
Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 724
Pain Catastrophizing (Pain Catastrophizing Scale)
The Pain Catastrophizing Scale is a 13-item questionnaire assessing catastrophic thoughts related to pain. The total score ranges from 0 to 52, with higher scores indicating greater pain catastrophizing and therefore a worse outcome
Time frame
Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Farraj Miguel
Lead sponsor
Université Libre de Bruxelles
Sponsor institution
Brussels Institute for Research and Innovation (INNOVIRIS)
Collaborator
moveUP bv
Collaborator
Source ClinicalTrials.gov